About Curevo
Curevo is a private company based in Bothell, Washington, incorporated in 2021 in Delaware. It has reported $109,997,327 raised in three offerings on Form D since January 2022. Its chief executive is George Simeon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2025 | Mar 18, 2025 | $42,414,174of $84.8M target | 11 | $3.8M | EquityRule 506(b) | Form D ↗ |
| Nov 10, 2022 | Nov 21, 2022 | $22,000,002of $26.0M target | 7 | $3.1M | EquityRule 506(b) | Form D ↗ |
| Dec 29, 2021 | Jan 12, 2022 | $45,583,151of $70.5M target | 7 | $6.5M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $109,997,327 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Curevo's Form D filed Mar 18, 2025.
MB
Mario Barro
Director
BB
Baeksik Bae
Director
CP
Charles Petty
Director
GM
Giovanni Mariggi
Director
Tal Zaks
Director
Also an executive chairman of the board at Averna Therapeutics and a director at Convergent Therapeutics.
MS
Moncef Slaoui
Director
GS
George Simeon
CEO and director
Earlier filings also listed Julie Brooks (executive officer, last listed Nov 2022) and Jae Uk Jeong (director, last listed Nov 2022).